Pneumococcal Disease: Who, What, and When?

PCE

English - February 10, 2022 14:10 - 17 minutes - 16 MB - ★★★★ - 6 ratings
Courses Education Science Life Sciences app education np education podcasts for credit app medicine pa education np medicine pa medicine ce podcasts app podcasts cme podcasts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Addressing Objections to HPV Vaccination

Next Episode: The New Array of Choices in Prostate Cancer—What’s Best for Your Patients? Part 1

In this first of two podcasts, Tracey M. Piparo, PA-C and Martin C. Mahoney, MD, PhD discuss the benefits of pneumococcal vaccination, review the types of pneumococcal vaccines currently available, and provide ACIP’s recently updated age-based and risk-based recommendations on when to use the new conjugated pneumococcal vaccines. This activity is available for CE/CME credit. Claim your credit at pce.is/pneu.

Contributors:

Martin C. Mahoney, MD, PhD
Professor
Department of Epidemiology and Environmental Health
University of Buffalo
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Dr Mahoney: consulting fees: Pfizer; consulting fees/fees for non-CME/CE services: Merck; fees for non-CME/CE services: GlaxoSmithKline, Sanofi.

Tracey M. Piparo, PA-C
Palliative Medicine
RWJ Barnabas Health
New Brunswick, New Jersey
Immediate Past President
New Jersey State Society of Physician Assistants

Ms. Piparo has no relevant financial relationships to disclose.